Text of Maria Millan's Statement on the Orchard Bubble Baby Decision
Here is the text of the statement by Maria T. Millan, president and CEO of the California stem agency, on Orchard’s decision to give up its license on the ADA-SCID treatment.
“The news that Orchard Therapeutics is returning OTL-101 to UCLA is wonderful news for families who have children with ADA-SCID. This means that UCLA will now be able to begin the …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.